This statistic shows the distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type. During this time period, osteoporosis drugs accounted for 19.5 percent of the total incrementally modified drugs approved in South Korea.
Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you The Korean War
Beginning of the conflict
3
Casualties
6
- Premium Statistic Number of military casualties during the Korean War 1950-1953
- Premium Statistic Number of civilian casualties during the Korean War 1950-1953
- Basic Statistic Korean War: U.S. military deaths by cause of death1950-1953
- Basic Statistic Korean War: U.S. military casualties during the Battle of Inchon September 1950
- Basic Statistic Korean War: U.S. military fatalities by casualty type and service branch 1950-1953
- Basic Statistic Korean War: death of communist POWs in American custody from 1950 to 1953
Other aspects of the war
3
Legacy in the U.S.
4
- Basic Statistic Total U.S. servicemembers and living veterans of major conflicts 1941-2021
- Premium Statistic U.S. Americans on the justification of military involvement 2019, by war
- Basic Statistic Number of visitors to the Korean War Veterans Memorial in the U.S. 2008-2023
- Premium Statistic U.S. population supporting the use of U.S. troops if North Korea invaded South Korea
Legacy in North & South Korea
7
- Premium Statistic GDP comparison between South and North Korea 2010-2022
- Premium Statistic Number of reunited family members divided by the Korean War 2000-2023
- Basic Statistic Attitudes toward North Korea in South Korea 2007-2023
- Premium Statistic Main reasons for unification with South and North Korea 2007-2023
- Premium Statistic Time required to achieve unification between South and North Korea 2013-2023
- Premium Statistic South Koreans' opinion on the priority in North Korea policy 2023
- Basic Statistic South Korean's opinions on ideal political system of unified Korea 2009-2016
Further related statistics
10
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's ad spending 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Sales of Johnson & Johnson 2006-2023 by region
- Johnson & Johnson's number of employees 2004-2023
- GSK's operating profit by division 2006-2021
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's ad spending 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Sales of Johnson & Johnson 2006-2023 by region
- Johnson & Johnson's number of employees 2004-2023
- GSK's operating profit by division 2006-2021
Samsung Securities. (August 25, 2017). Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type [Graph]. In Statista. Retrieved June 10, 2024, from https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities. "Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type." Chart. August 25, 2017. Statista. Accessed June 10, 2024. https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities. (2017). Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type. Statista. Statista Inc.. Accessed: June 10, 2024. https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities. "Distribution of Incrementally Modified Drugs Approved in South Korea from 2009 to 2016, by Type." Statista, Statista Inc., 25 Aug 2017, https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities, Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type Statista, https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/ (last visited June 10, 2024)
Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type [Graph], Samsung Securities, August 25, 2017. [Online]. Available: https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/